Wei Wu

机构：Agency for Science, Technology and Research, Union Hospital, National University of Singapore, Utrecht University, Chinese Academy of Medical Sciences & Peking Union Medical College, Singapore Immunology Network, Wuhan University, Nanfang Hospital, Children's Hospital of Zhejiang University, IONICS Mass Spectrometry (Canada), Wangjing Hospital of China Academy of Chinese Medical Sciences, DermResearch (United States), National Taiwan University Hospital, Renmin Hospital of Wuhan University, A*STAR Graduate Academy, Huazhong University of Science and Technology, Southern Medical University, Berea College · ORCID：0000-0002-1092-603X

发表论文 146 篇 · 总被引 5051 次 · h-index 34

代表论文

• High-quality peptide evidence for annotating non-canonical open reading frames as human proteins (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 37)
• PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity (2024 · Nature Communications · 被引 26)
• Immune-Modulating Dual-Targeted Nanomaterials for Low-Temperature Photothermal–Photodynamic–Chemodynamic Therapy of Osteosarcoma Targeting Tumor and Endothelial Cells (2025 · ACS Nano · 被引 16)
• Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates Aβ pathogenesis-induced neuroinflammation in 5 × FAD mice (2024 · Life Sciences · 被引 9)
• An expanded reference catalog of translated open reading frames for biomedical research (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 7)
• Patient-Derived Tumor Organoids: A Platform for Precision Therapy of Colorectal Cancer (2025 · Cell Transplantation · 被引 7)